News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Dr. Blagosklonny’s Battle With Cancer (Part 1)

News

January 22, 2024
PRESS RELEASE: On January 3, 2024, Mikhail V. Blagosklonny M.D., Ph.D., published a new brief report in Oncoscience (Volume 11), entitled, “My battle with cancer. Part 1.” continue reading »

Mutational Signatures of Cancer: Can Passengers Set a Direction for Prognosis?

News

January 19, 2024
PRESS RELEASE: A new editorial paper was recently published in Oncoscience, entitled, “The mutational signatures of cancer: can passengers set a direction for prognosis?” continue reading »

ATR Inhibition Using Gartisertib in Patient-derived Glioblastoma Cell Lines

News

January 17, 2024
PRESS RELEASE: On January 16, 2024, a new research paper was published in Oncotarget, entitled, “ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.” continue reading »

Aberrant RBMX Expression Relevant for Cancer Prognosis and Immunotherapy Response

Aging

January 17, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 1, entitled, “Aberrant RBMX expression is relevant for cancer prognosis and immunotherapy response.” continue reading »

Reductive Carboxylation of Glutamine as a Potential Target in AML

News

January 16, 2024
PRESS RELEASE: On December 1, 2023, a new editorial was published in Oncotarget, entitled, “Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia.” continue reading »